Trastuzumab Deruxtecan (DS-8201a): The Latest Research and Advances in Breast Cancer

Αngeliki Andrikopoulou; Eleni Zografos; Michalis Liontos; Konstantinos Koutsoukos; Meletios A Dimopoulos; Flora Zagouri

doi:10.1016/j.clbc.2020.08.006

Related publications

Article2014

Use of Trastuzumab for Breast Cancer: The Role of Age

Walter Mazzucco, Marta Rossi, Rosanna Cusimano, Matteo Franchi, Martina Bonifazi, Francesco Alessandro Mistretta, Francesco Vitale, Walter Ricciardi, Eva Negri, Stefania Boccia, Carlo La Vecchia

Article2014

Use of trastuzumab for breast cancer: the impact of age.

Walter Mazzucco, Francesco Vitale, Marta Rossi, Walter Ricciardi, Carlo La Vecchia, Martina Bonifazi, Matteo Franchi, Eva Negri, Rosanna Cusimano, Francesco Alessandro Mistretta, Stefania Boccia

Article2013

Trastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study

Martina Bonifazi, Matteo Franchi, Marta Rossi, Lorenzo Moja, Alberto Zambelli, Antonella Zambon, Giovanni Corrao, Carlo La Vecchia, Carlo Zocchetti, Eva Negri

Article2024

Real-world evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing gynecological malignancies

Αngeliki Andrikopoulou, Flora Zagouri, Kallirroi Goula, Dimitrios Haidopoulos, Nikolaos Thomakos, Anna Svarna, Meletios A Dimopoulos, Michalis Liontos

Article2015

Trastuzumab for HER2+ metastatic breast cancer in clinical practice: Cardiotoxicity and overall survival

Marta Rossi, Greta Carioli, Martina Bonifazi, Alberto Zambelli, Matteo Franchi, Lorenzo Moja, Antonella Zambon, Giovanni Corrao, Carlo La Vecchia, Carlo Zocchetti, Eva Negri